Cancer cells can outcompete CD8 + T cells for taurine by overexpressing the taurine transporter SLC6A6, leading to taurine depletion in T cells, which induces cell death and dysfunction, thereby promoting tumor progression. Here, SLC6A6 is linked to neoplasm.